Replies to post #218652 on Avid Bioservices Inc (CDMO)

[BioBS2012]

Disclosures: Bruce A. Chabner: Sanofi, Allergan, Epizyme, PharmaMar, GlaxoSmithKline, Peregrine, Pharmacyclics (C/A); Eli Lilly (H); Gilead, Merck, Epizyme, Curis, Onyx, Bristol-Myers Squibb, Amgen, Celgene, Exelixis, Rigel (OI).

-------------------------------

This may need more looking into, because the puzzle pieces become confusing and I wonder if Bruce Chabner will become a PS Targeting advocate because now I am confused that he does not list Peregrine as a disclosure above ??

See red highlight !!

[Bungler]

This appears to be the same Dr. Robert Schwartz who authored "Peregrine Pharmaceutical's Bavituximab: It's Time to Throw in the Towel," on the Seeking Alpha website.

It's Time to Throw in the Towel, by Dr. Robert Schwartz